Francesca Ceccherini - Silberstein is currently associate professor at the chair of Virology, and coordinator of the PhD course in Microbiology, Immunology, Infectious Diseases, and Transplants (MIMIT), at the University of Rome "Tor Vergata". From 2017 is Scientific Director and Vice-president of the Italian Foundation of HCV Virology Italian Resistance Network Study Group – Fondazione VIRONET C.
She obtained her PhD in Biology at the University of Munich "Ludwig-Maximilians", Germany, in 2001. She has been involved in research activity on viruses since 1996. Her research interests and expertise are on HIV infection, antiviral drugs, HIV-HBV-HCV drug-resistance, viral pathogenesis, viral tropism, viral evolution and dynamics, genotypic (by Sanger and NGS sequencing), structural and functional analysis of viral proteins. She published 234 full papers in prestigious journals (including J of Infectious Diseases, Retrovirology, J of Virology, J of Hepatology, Hepatology, Antiviral Therapy, J of Antimicrob Chemother, PlosOne, Antimicrob Agents Chemother), with a median impact factor of 4.82; H index of 40. She attended at numerous National and International Conferences presenting her work, with more than 80 Invited Lectures, 200 Oral Presentations, and 150 Posters. She received the G. B. Rossi 2008 prize, as the best researcher in the HIV-field for the best publication (F. Ceccherini Silberstein et al., J Virol 2007).
She is a member of the scientific committee of the Italian Cohort of Antiretroviral-Naïve Patients (ICONA) Foundation, member of the IAS-USA HIV Drug Resistance Mutations Panel, and from 2014-2017 was aMember of the Coordinator and Scientific Comity of the Italian Association of Liver Study (AISF). Member of editorial board in BMJ Sexually Transmitted Infections, PLoS ONE and AIDS Reviews. She cooperates with many nationally and internationally recognized scientific researchers through several grants from the Italian National Institute of Health, the Ministry of University and Scientific Research, and the European Community.